Pfizer’s abrocitinib aces 5th phase 3 on route to FDA decision

Pfizer’s abrocitinib aces 5th phase 3 on route to FDA decision
ntaylor
Wed, 11/11/2020 – 07:46

Published on Wed, 11 Nov 2020 12:46:11 +0000 and brought to you by Apptigent PowerTools